Opioids And Jews

Purdue Pharma is a firm that made Oxycontin and a very handsome profit. With sales of USD31 billion and rising it is easy to see why Capitalist Swine liked it.
fat cat
fat cat 2
It also brought us the #Opioid Epidemic, which meant addiction and death. Once people are hooked it is difficult to stop. Overdosing is another issue. It was the most successful killer drug in America until #2011. That role has been taken over by heroin and fentanyl.

#Purdue Pharma was set up and run by the #Sackler Family, that is to say by Jews on the make. Two of the perpetrators are #Mortimer Sackler and #Raymond Sackler

Opioid, the word is an ugly variant of Opium; they are both addictive and used by pleasure seekers. One form is OxyContin marketed by Purdue Pharma as a pain killer. It also turned out to be a killer - of its users as well as being addictive. These facts came to light after the Sackler Family got seriously rich, selling it and killing thousands.

Mortimer and Raymond Sackler are, like the rest of them, Jews of the sort that worships money. It turns out that when they went bankrupt, avoiding liability for their victims they siphoned off some $10 billion. See e.g. Drug Dealing Jews Make Off With Ill Gotten Gains. Now, in February 2021 the Wall Street Journal tells us that They Stole Circa $10 Gigabucks With Lawyers Help Or Not.

Opioid ex Wiki
Opioids are substances that, when reaching opioid receptors, have effects similar to those of morphine.[2] Medically they are primarily used for pain relief, including anesthesia.[3] Other medical uses include suppression of diarrhea, replacement therapy for opioid use disorder, reversing opioid overdose, and suppressing cough.[3] Extremely potent opioids such as carfentanil are approved only for veterinary use.[4][5][6] Opioids are frequently used non-medically for their euphoric effects or to prevent withdrawal.[7]

Side effects of opioids may include itchiness, sedation, nausea, respiratory depression, constipation, and euphoria. Long-term use can cause tolerance, meaning that increased doses are required to achieve the same effect, and physical dependence, meaning that abruptly discontinuing the drug leads to unpleasant withdrawal symptoms.[8] The euphoria attracts recreational use and frequent, escalating recreational use of opioids typically results in addiction. An overdose or concurrent use with other depressant drugs like benzodiazepines or alcohol commonly results in death from respiratory depression.[9]

Opioids act by binding to opioid receptors. They are found principally in the central and peripheral nervous system and the gastrointestinal tract. These receptors mediate both the psychoactive and the somatic effects of opioids. Opioid drugs include partial agonists, like the anti-diarrhea drug loperamide and antagonists like naloxegol for opioid-induced constipation. They do not cross the blood-brain barrier, but can displace other opioids from binding to those receptors.[citation needed]

69,000 people worldwide die of opioid overdose each year and 15 million people have an opioid addiction.[10]

Because opioids are addictive and may result in fatal overdose, most are controlled substances. In 2013, between 28 and 38 million people used opioids illicitly (0.6% to 0.8% of the global population between the ages of 15 and 65).[11] In 2011, an estimated 4 million people in the United States used opioids recreationally or were dependent on them.[12] As of 2015, increased rates of recreational use and addiction were attributed to over-prescription of opioid medications and inexpensive illicit heroin.[13][14][15] Conversely, fears about over-prescribing, exaggerated side effects, and addiction from opioids are similarly blamed for under-treatment of pain.[16][17]

 

Purdue Pharma ex Wiki
Purdue Pharma L.P. is a privately held pharmaceutical company founded by John Purdue Gray. It is (or respectively was) owned principally by members of the Sackler family as descendants of Mortimer and Raymond Sackler.[1][2] In 2007, it paid out one of the largest fines ever levied against a pharmaceutical firm for mislabeling its product OxyContin, and three executives were found guilty of criminal charges.[3][4] Although the company shifted its focus to abuse-deterrent formulations, Purdue continued to market and sell opioids as late as 2019, and continued to be involved in lawsuits around the opioid epidemic in the United States.[5][6] Purdue filed for Chapter 11 bankruptcy protection on September 15, 2019 in New York.[7][8]

On October 21, 2020 it was reported that Purdue had reached a settlement potentially worth $8.3bn, admitting that it "knowingly and intentionally conspired and agreed with others to aid and abet" doctors dispensing medication "without a legitimate medical purpose". Members of the Sackler family will additionally pay $225m and the company will close. [9][10]

 

OxyContin ex Wiki
Oxycodone, sold under the brand name OxyContin (which is the extended release form) among others, is an opioid medication used for treatment of moderate to severe pain, and a common drug of abuse.[12][13] It is usually taken by mouth, and is available in immediate-release and controlled-release formulations.[12] Onset of pain relief typically begins within fifteen minutes and lasts for up to six hours with the immediate-release formulation.[12] In the United Kingdom, it is available by injection.[14] Combination products are also available with paracetamol (acetaminophen), ibuprofen, naloxone, and aspirin.[12]

Common side effects include euphoria, constipation, nausea, vomiting, loss of appetite, drowsiness, dizziness, itching, dry mouth, and sweating.[12] Severe side effects may include addiction, dependence, hallucinations, respiratory depression (a reduction in breathing), bradycardia, and low blood pressure.[12] Those allergic to codeine may also be allergic to oxycodone.[12] Use of oxycodone in early pregnancy appears relatively safe.[12] Opioid withdrawal may occur if rapidly stopped.[12] Oxycodone acts by activating the μ-opioid receptor.[15] When taken by mouth, it has roughly 1.5 times the effect of the equivalent amount of morphine.[16]

Oxycodone was first made in Germany in 1916 from thebaine.[17] It is available as a generic medication.[12] In 2017, it was the 52nd most commonly prescribed medication in the United States, with more than fifteen million prescriptions.[18][19] A number of abuse-deterrent formulations are available, such as in combination with naloxone.[13][20]

 

Sackler Family ex Wiki
The Sackler family is an American family, many of whom are known for founding and owning the pharmaceutical company Purdue Pharma. Purdue Pharma, and by extension some members of the family, have faced criticism and lawsuits regarding over-prescription of addictive pharmaceutical drugs, including Oxycontin, and Purdue Pharma's role in the North American opioid crisis.[1][2][3] According to the New Yorker, Purdue Pharma played a "special role" in the opioid crisis because the company "was the first to set out, in the nineteen-nineties, to persuade the American medical establishment that strong opioids should be much more widely prescribed—and that physicians’ longstanding fears about the addictive nature of such drugs were overblown."

 

Two Kinds Of Truth by Michael Connelly
Is a novel about crime in Los Angeles, major systematic drug using addicts to get pills illegally. It is an industry making thousands or millions. The Sackler top down methods made billions. 

 

Opioid Epidemic ex Wiki
The opioid epidemic, also referred to as the opioid crisis, is the rapid increase in the overuse, misuse/abuse, and overdose deaths attributed either in part or in whole to the class of drugs called opiates/opioids since the 1990s. It includes the significant medical, social, psychological, demographic and economic consequences of the medical, non-medical, and recreational abuse of these medications.

A chart outlining the structural features that define opiates and opioids, including distinctions between semi-synthetic and fully synthetic opiate structures
Fentanyl. 2 mg (white powder to the right) is a lethal dose in most people.[1] US penny is 19 mm (0.75 in) wide.

Opioids are a diverse class of moderate to strong painkillers, including oxycodone (commonly sold under the trade names OxyContin and Percocet), hydrocodone (Vicodin, Norco), and fentanyl, which is a very strong painkiller that is synthesized to resemble other opiates such as opium-derived morphine and heroin.[2] The potency and availability of these substances, despite the potential risk of addiction and overdose, have made them popular both as medical treatments and as recreational drugs. Due to the sedative effects of opioids on the respiratory center of the medulla oblongata, opioids in high doses present the potential for respiratory depression and may cause respiratory failure and death.[3]

Opioids are highly effective for treating acute pain,[4] but there is strong debate over whether they are effective in treating chronic or high impact intractable pain,[5] as the risks may outweigh the benefits.[5]

 

 


 

Drug Dealing Jews Make Off With Ill Gotten Gains  [ 18 September 2019 ]
QUOTE
Drug maker Purdue Pharma, which is being blamed for jump-starting America's opioid crisis with its aggressive marketing of Oxycontin, has filed for bankruptcy. 

Purdue Pharma, owned by the [ allegedly ] British-American Sackler family, filed for bankruptcy protection on Sunday night in a federal bankruptcy court in White Plains, New York, after reaching a tentative settlement deal worth up to $12billion with state and local governments.

The Sacklers expressed sympathy on Sunday night but refused to take responsibility for the nation's opioid epidemic.............

The family agreed to pay at least $3billion in the settlement plus contribute the company itself, which is to be reformed with its future profits going to the company's creditors.............

A court filing by the New York Attorney General's office on Friday contended that Sackler family members used Swiss and other hidden accounts to transfer $1billion to themselves. The discovery of the transfers bolsters several states' claims that family members worked to shield its wealth because of the growing legal threats against them and Purdue.
UNQUOTE
They set this one up; now they are walking away laughing up their sleeves. Down to their last few billion; tough isn't it? The Mail assumes that we don't know that the Sacklers are Jews on the make so it is not censoring this one, just concealing the truth about them. The Guardian does have a small mention, just once in Meet the Sacklers the family feuding over blame for the opioid crisis.

 

Jews Slide Out From Under After Killing 47 Thousand People Using OxyContin  [ 22 October 2020 ]
QUOTE
Purdue Pharma, the company that makes OxyContin, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion for its alleged role in fueling America's opioid epidemic, Justice Department officials confirmed Wednesday.

United States Deputy Attorney General. Jeffrey A. Rosen announced the deal in a press conference Wednesday morning as he vowed to 'turn the tide on the opioid crisis ravaging the country'. Rosen said the deal is still subject to bankruptcy court approval.

Under the deal the Connecticut-based company, owned by the wealthy Sackler family, will plead guilty to three criminal charges filed in federal court in New Jersey Wednesday. 

The three counts include conspiracy to defraud the United States and violating federal anti-kickback laws............

The deal does not release any of the company's executives or owners - including members of the Sackler family - from criminal liability and a criminal investigation is still ongoing.
UNQUOTE
More Jews, more crime. You will have seen them whining about their problems with naughty little Adolf and their Holocaust® Story. You might wonder just why he didn't like them. They keep very quiet about that then the Sackler mob leave you to wonder if he was right. NB They are upper world criminals so they will not go to prison.

 

Jews Stole Circa $10 Gigabucks With Lawyers' Help Or Not  [ 17 February 2021 ]
QUOTE
The law firms defending Purdue Pharma LP in probes into its OxyContin painkiller didn’t disclose an existing deal with Purdue’s owners to keep information shared between them confidential when the drug maker filed for bankruptcy.

Skadden, Arps, Slate, Meagher & Flom LLP and WilmerHale received court permission in November 2019 to continue working for Purdue after it sought chapter 11 protection. But the firms’ nondisclosure of the agreement with the members of the Sackler family who own Purdue, and whose interests are at odds with company creditors, skirted bankruptcy rules meant to reveal potential conflicts of interest, bankruptcy experts said.

Earlier this week, Michael Quinn, a lawyer representing five people with wrongful death and personal injury claims against Purdue, questioned whether the 2018 defense agreement restricted what Skadden and WilmerHale could disclose to creditors as they have probed whether they can recover billions of dollars from the drugmaker’s owners. Even though the law firms have represented Purdue for years, they have additional obligations to company creditors while the company is in chapter 11.

A separate committee of Purdue creditors has been probing the transfer of billions of dollars from Purdue to the Sacklers before the company filed bankruptcy, according to court documents. The committee is examining if these roughly $10 billion in transfers to the Sacklers can be recovered for the benefit of Purdue creditors, court papers say. Mr. Quinn said in his letter he is concerned that the obligation in the defense agreement to keep Sackler information confidential conflicted with Skadden’s and WilmerHale’s duties in bankruptcy to Purdue and its creditors.

The Sacklers have consistently denied throughout the bankruptcy case that the transfers were improper and said more than half the money was used to pay taxes or invested in international ventures. However, they offered to cede control of Purdue and pay a $3 billion cash settlement to resolve creditor claims against them.

Whether Purdue creditors and the Sacklers are able to strike an agreement that would help facilitate the company’s reorganization in chapter 11 is a key open issue in the company’s bankruptcy case. Purdue said when it filed bankruptcy that it had formed a special committee to review distributions from the company to the Sacklers.

The 2018 joint-defense agreement between Purdue and Sackler family members who own the drugmaker was made public in December along with hundreds of other previously sealed court records that were unsealed at the request of The Wall Street Journal and other media organizations.

Skadden lawyer Patrick Fitzgerald denied that the firm concealed the agreement, and said Skadden complied with bankruptcy disclosure obligations in a letter filed Wednesday responding to Mr. Quinn.

Skadden didn’t mention the defense agreement in its 2019 bankruptcy retention application because the agreement was between Purdue and the Sacklers, with Skadden only acting as legal counsel on Purdue’s behalf, Mr. Fitzgerald said.

Bankruptcy experts contacted by the Journal disagreed with Mr. Fitzgerald’s argument and said the defense agreement should have been disclosed in the firm’s retention application under chapter 11 disclosure rules. Disclosure is a fundamental part of bankruptcy, and chapter 11 rules concerning what links a bankrupt company’s advisers must disclose are broad.

“This is kind of a no-brainer that this information should have been disclosed at the time counsel sought to be employed,” said retired bankruptcy judge Carol Kenner, who served on the Massachusetts bench from 1986 to 2004. In 2003, she made an oft-cited ruling against a law firm over its failure to disclose a joint defense agreement between a company and its officers—a situation that she said was similar to Purdue’s case.

Representatives for Skadden, WilmerHale and Purdue didn’t respond to requests for comment. A representative for one main branch of the Sackler family, the descendants of Mortimer Sackler, declined to comment. Lawyers for the other main branch, the descendants of Raymond Sackler, didn’t respond to requests for comment about the defense agreement.

U.S. Bankruptcy Judge Robert Drain, who is overseeing Purdue’s chapter 11 case and approved the retention of Skadden and WilmerHale, hasn’t responded to questions raised in Mr. Quinn’s letter about disclosure of the defense agreement.

Skadden and WilmerHale, two of the largest U.S.-based law firms by revenue, started defending Purdue in federal probes into the marketing and sales of opioid products years before the company filed for chapter 11 in September 2019. Stamford, Conn.-based Purdue filed for bankruptcy to try to resolve thousands of lawsuits accusing the company of helping to fuel the opioid epidemic. Purdue said when it filed bankruptcy that although the country “faces a profound problem of opioid abuse,” the company denied liability and disputed that its marketing of opioid medications caused the crisis.

The drug maker pleaded guilty in November to three federal felony charges related to the marketing and distribution of its flagship product, OxyContin. Skadden defended Purdue in the Justice Department’s criminal investigation.

After their court-approved retention, Skadden filed billing records listing entries for “joint defense” calls with lawyers from other firms that represented the Sacklers. Mr. Fitzgerald’s response letter this week pointed to those billing records, saying there was no effort to conceal the defense agreement. Lawyers representing a committee of Purdue unsecured creditors were provided a copy of the information sharing agreement between Purdue and the Sacklers in July 2020 during the committee’s own investigations, his letter said.

Lawyers representing the Purdue creditors committee didn’t respond to messages seeking comment.
UNQUOTE
This is a messy case; the intent to defraud is blatant. The duties of various players  is not.

 

Opioid Drug Dealers Offer $26 Billion To Their Victims  [ 20 April 2021 ]
QUOTE
J&J, along with the three largest drug distributors in the country, McKesson Corp. MCK 0.95% , AmerisourceBergen Corp. ABC 0.55% and Cardinal Health Inc., CAH 0.72% have offered to pay a collective $26 billion to resolve their piece of the litigation. Talks between the companies and states have been under way since late 2019 but have been delayed by the pandemic as well as details around attorneys’ fees and how to account for communities that opt out of the deal.

Israel-based Teva also made a proposal in 2019 to resolve the cases, offering to donate a decade’s worth of opioid-addiction treatment drugs along with a cash payment of $250 million.
UNQUOTE
A billion is still a lot of money but it rolls off the tongue nicely. Politicians don't care; it is not their money. The tax payers are being screwed again. For the companies it is the Shareholders that take a beating. But the Directors stay out of prison. That is the real issue. The Sackler Family, the Jews that supply OxyContin snuck out from under long ago. Going bankrupt was their trick.

 

https://www.icij.org/investigations/swiss-leaks/as-american-public-turned-to-opioids-oxycontins-founder-tapped-a-private-swiss-bank/